Atea Pharmaceuticals (AVIR) Payables (2020 - 2022)
Historic Payables for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $1.1 million.
- Atea Pharmaceuticals' Payables fell 9496.17% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.1 million, marking a year-over-year decrease of 9496.17%. This contributed to the annual value of $4.5 million for FY2021, which is 745666.67% up from last year.
- Latest data reveals that Atea Pharmaceuticals reported Payables of $1.1 million as of Q3 2022, which was down 9496.17% from $13.9 million recorded in Q2 2022.
- Atea Pharmaceuticals' Payables' 5-year high stood at $22.2 million during Q3 2021, with a 5-year trough of $60000.0 in Q4 2020.
- Moreover, its 3-year median value for Payables was $4.5 million (2020), whereas its average is $7.2 million.
- In the last 5 years, Atea Pharmaceuticals' Payables surged by 745666.67% in 2021 and then plummeted by 9496.17% in 2022.
- Over the past 3 years, Atea Pharmaceuticals' Payables (Quarter) stood at $60000.0 in 2020, then surged by 7456.67% to $4.5 million in 2021, then tumbled by 75.34% to $1.1 million in 2022.
- Its Payables was $1.1 million in Q3 2022, compared to $13.9 million in Q2 2022 and $3.7 million in Q1 2022.